Alto Neuroscience

Alto Neuroscience

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-184
-157
EBITDA
-23,450
-26,963
-25,508
-15,450
EBIT
-24,661
-27,147
-25,692
-15,607
Net Income
-25,124
-27,638
-26,237
-16,182
Net Change In Cash
0
0
0
0
Free Cash Flow
-20,756
-19,760
-27,647
-11,516
Cash
319,344
243,733
263,762
176,484
Basic Shares
46,531
42,813
32,893
31,923

Annual Financials

Values in thousands2025-09-302024-09-302023-09-302022-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-661
-502
-373
-342
EBITDA
-60,108
-62,304
-34,562
-27,368
EBIT
-60,769
-62,806
-34,935
-27,710
Net Income
-63,238
-61,431
-36,305
-27,710
Net Change In Cash
0
0
0
0
Free Cash Flow
-51,793
-49,499
-33,918
-21,126
Cash
176,484
168,229
82,548
48,344
Basic Shares
28,852
24,602
26,883
25,574

Earnings Calls

QuarterEPS
2026-09-30
-$0.54
2026-06-30
-$0.65
2026-03-31
-$0.80
2025-12-31
-$0.45